Incyte (INCY) Change in Intangibles (2023 - 2026)
Incyte (INCY) reported Change in Intangibles of $5.0 million for Q1 2026, down 80.0% quarter-over-quarter from $25.0 million in Q3 2025.
Incyte (INCY) Change in Intangibles (2023 - 2026) Analysis & Trends
Incyte has reported Change in Intangibles for 4 years, with the latest figure at $5.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Intangibles changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at $30.0 million (up 115.83% YoY), and the FY2025 full-year result was $25.0 million, up 79.86% from the prior year.
- Change in Intangibles for Q1 2026 stood at $5.0 million, down from $25.0 million in the prior quarter.
- The five-year high for Change in Intangibles was $25.0 million in Q3 2025, with the low at $1.4 million in Q2 2024.
- Historically, Change in Intangibles has averaged $11.8 million across 4 years, with a median of $12.5 million in 2024.
- The largest YoY upside for Change in Intangibles was 100.0% in 2025 against a maximum downside of 100.0% in 2025.
- Incyte's Change in Intangibles stood at $15.0 million in 2023, then fell by 16.67% to $12.5 million in 2024, then surged by 100.0% to $25.0 million in 2025, then tumbled by 80.0% to $5.0 million in 2026.
- The last three Change in Intangibles figures came in at $5.0 million (Q1 2026), $25.0 million (Q3 2025), and $12.5 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Sep 30, 2025 | 25.00 Mn |
| Sep 30, 2025 | 25.00 Mn |
| Sep 30, 2024 | 12.50 Mn |
| Sep 30, 2024 | 12.50 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2023 | 15.00 Mn |
| Mar 31, 2023 | 15.00 Mn |